---
title: "nCage Therapeutics and Ryvu have agreed to a research collaboration"
description: "A collaboration to develop a next-generation antibody-drug conjugate platform built on the TRAP-cage."
url: https://www.ncage.org/en/news/ncage-therapeutics-and-ryvu-have-agreed-to-a-research-collaboration
language: en
date: 2024-10-29
site: nCage Therapeutics
---

# nCage Therapeutics and Ryvu have agreed to a research collaboration

2024-10-29 · nCage Therapeutics

nCage Therapeutics and Ryvu have agreed to a research collaboration to develop a next-generation antibody-drug conjugate (ADC) platform.

nCage has developed a TRAP-cage platform in which the protein cages are synthetic virus-like particles (VLPs). They can display biological material on their surface, or transport molecules such as nucleic acids or proteins into the interior of a target cell.

This collaboration focuses on the latter, where the TRAP-cage can be used as a novel drug delivery system that could improve the efficacy and safety of current ADCs.

[Press release](https://www.ncage.org/docs/press-ryvu-collaboration.pdf)